Loading...
OTCM
MGROF
Market cap21mUSD
Dec 05, Last price  
0.42USD
1D
4.20%
1Q
-14.14%
IPO
81.04%
Name

MUSTGROW BIOLOGICS CORP.

Chart & Performance

D1W1MN
OTCM:MGROF chart
P/E
P/S
76.19
EPS
Div Yield, %
Shrs. gr., 5y
15.33%
Rev. gr., 5y
372.54%
Revenues
398k
-91.55%
12,417109,0152,1022,0000012,8696,4794,712,200398,018
Net income
-5m
L+622.18%
-582,734-20,443-36,451-1,893,377-1,518,038-3,309,926-3,063,875-5,565,841-676,940-4,888,722
CFO
-4m
L+1,113.95%
-580,566-2,567-6,740-968,347-1,352,513-2,578,823-2,411,779-3,257,538-294,764-3,578,296

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

MustGrow Biologics Corp., an agricultural biotech company, focuses om development and commercialization of natural biopesticide, biofumigants, and bioherbicides derived from mustard seed. It provides preplant soil biofumigation, a technology to treat soil-borne diseases and pests for various crops, including fruit, vegetables, and other crops. The company is also developing bioherbicide to treat unwanted plant growth for use in organic agriculture, home, and garden markets, as well as agriculture markets; and postharvest food preservation, an application in sprout, disease, and pathogen treatment for storage and food preservation markets. In addition, it focuses on providing CannaPM, an active ingredient to treat fungal soil diseases, as well as foliar diseases. The company was formerly known as Duport Capital Ltd. and changed its name to MustGrow Biologics Corp. in March 2018. MustGrow Biologics Corp. was incorporated in 2014 and is headquartered in Saskatoon, Canada.
IPO date
Jul 10, 2019
Employees
Domiciled in
CA
Incorporated in
CA

Valuation

Title
CAD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT